# A Multicenter, Double-blind, Randomized, Parallel-group, Pilot Study of 12-week Duration to Assess the Short-term Safety and Tolerability of Lorcaserin Plus Two Doses of Immediate-Release Phentermine-HCl Compared With Lorcaserin Alone in Overweight and Obese Adults

> **NCT01987427** · PHASE4 · COMPLETED · sponsor: **Eisai Inc.** · enrollment: 344 (actual)

## Conditions studied

- Chronic Weight Management

## Interventions

- **DRUG:** lorcaserin + phentermine placebo
- **DRUG:** lorcaserin + phentermine-HCl + phentermine placebo
- **DRUG:** lorcaserin + phentermine-HCl

## Key facts

- **NCT ID:** NCT01987427
- **Lead sponsor:** Eisai Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10-30
- **Primary completion:** 2014-08
- **Final completion:** 2014-09-03
- **Target enrollment:** 344 (ACTUAL)
- **Last updated:** 2019-09-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01987427

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01987427, "A Multicenter, Double-blind, Randomized, Parallel-group, Pilot Study of 12-week Duration to Assess the Short-term Safety and Tolerability of Lorcaserin Plus Two Doses of Immediate-Release Phentermine-HCl Compared With Lorcaserin Alone in Overweight and Obese Adults". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01987427. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*